The statewide Adderall shortage that the Food and Drug Administration (FDA) originally identified in October is anticipated to endure, with many pharmacies stating they still can’t acquire the prescription.
The medication is frequently employed to treat attention deficit hyperactivity disorder (ADHD). According to CDC data, an estimated six million children ages 3 to 17 were diagnosed with ADHD between 2016 and 2019, with 62 percent of those children using ADHD medication. Adderall is not the only treatment for ADHD, but it is one of the most common.
The official explanation cited by the FDA for the shortfall is “demand rise.” However, the firm that manufactures the medicine, Alvogen, has provided little information.
The FDA estimates that supplies of 5mg Adderall pills will recover by early March, 30mg supplies by mid-March, and 10mg, 15mg, and 20mg supplies by mid-April.
“Until supply is restored, health care professionals and their patients have access to alternate medicines, including the extended-release version of amphetamine mixed salts, for amphetamine mixed salts’ recognized indications,” the government noted in October. Individuals should collaborate with their healthcare providers to identify the optimal course of treatment.